Literature DB >> 26614381

Tubular Secretion in CKD.

Astrid M Suchy-Dicey1, Thomas Laha2, Andrew Hoofnagle2, Rick Newitt3, Tammy L Sirich4, Timothy W Meyer4, Ken E Thummel5, N David Yanez6, Jonathan Himmelfarb3, Noel S Weiss7, Bryan R Kestenbaum8.   

Abstract

Renal function generally is assessed by measurement of GFR and urinary albumin excretion. Other intrinsic kidney functions, such as proximal tubular secretion, typically are not quantified. Tubular secretion of solutes is more efficient than glomerular filtration and a major mechanism for renal drug elimination, suggesting important clinical consequences of secretion dysfunction. Measuring tubular secretion as an independent marker of kidney function may provide insight into kidney disease etiology and improve prediction of adverse outcomes. We estimated secretion function by measuring secreted solute (hippurate, cinnamoylglycine, p-cresol sulfate, and indoxyl sulfate) clearance using liquid chromatography-tandem mass spectrometric assays of serum and timed urine samples in a prospective cohort study of 298 patients with kidney disease. We estimated GFR by mean clearance of creatinine and urea from the same samples and evaluated associations of renal secretion with participant characteristics, mortality, and CKD progression to dialysis. Tubular secretion rate modestly correlated with eGFR and associated with some participant characteristics, notably fractional excretion of electrolytes. Low clearance of hippurate or p-cresol sulfate associated with greater risk of death independent of eGFR (hazard ratio, 2.3; 95% confidence interval, 1.1 to 4.7; hazard ratio, 2.5; 95% confidence interval, 1.0 to 6.1, respectively). Hazards models also suggested an association between low cinnamoylglycine clearance and risk of dialysis, but statistical analyses did not exclude the null hypothesis. Therefore, estimates of proximal tubular secretion function correlate with glomerular filtration, but substantial variability in net secretion remains. The observed associations of net secretion with mortality and progression of CKD require confirmation.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; epidemiology and outcomes; proximal tubule

Mesh:

Year:  2015        PMID: 26614381      PMCID: PMC4926962          DOI: 10.1681/ASN.2014121193

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

Review 1.  Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Authors:  Garabed Eknoyan; Thomas Hostetter; George L Bakris; Lee Hebert; Andrew S Levey; Hans-Henrik Parving; Michael W Steffes; Robert Toto
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Authors:  Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

Review 3.  Uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

4.  A predictive model for progression of chronic kidney disease to kidney failure.

Authors:  Navdeep Tangri; Lesley A Stevens; John Griffith; Hocine Tighiouart; Ognjenka Djurdjev; David Naimark; Adeera Levin; Andrew S Levey
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

5.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Authors:  Carmen A Peralta; Michael G Shlipak; Suzanne Judd; Mary Cushman; William McClellan; Neil A Zakai; Monika M Safford; Xiao Zhang; Paul Muntner; David Warnock
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

6.  Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.

Authors:  Yasuhiro Tsutsumi; Tsuneo Deguchi; Mikihisa Takano; Akira Takadate; W Edward Lindup; Masaki Otagiri
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

7.  Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.

Authors:  Tsuneo Deguchi; Sumio Ohtsuki; Masaki Otagiri; Hitomi Takanaga; Hiroshi Asaba; Shinobu Mori; Tetsuya Terasaki
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

8.  Determination of o-cresol by gas chromatography and comparison with hippuric acid levels in urine samples of individuals exposed to toluene.

Authors:  L C Amorim; E M Alvarez-Leite
Journal:  J Toxicol Environ Health       Date:  1997-03

Review 9.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

10.  Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.

Authors:  Ruben Poesen; Liesbeth Viaene; Kristin Verbeke; Kathleen Claes; Bert Bammens; Ben Sprangers; Maarten Naesens; Yves Vanrenterghem; Dirk Kuypers; Pieter Evenepoel; Björn Meijers
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

View more
  39 in total

1.  Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model.

Authors:  Munsoor A Hanifa; Martin Skott; Raluca G Maltesen; Bodil S Rasmussen; Søren Nielsen; Jørgen Frøkiær; Troels Ring; Reinhard Wimmer
Journal:  Metabolomics       Date:  2019-08-17       Impact factor: 4.290

2.  Environment-Wide Association Study of CKD.

Authors:  Jeonghwan Lee; Sohee Oh; Habyeong Kang; Sunmi Kim; Gowoon Lee; Lilin Li; Clara Tammy Kim; Jung Nam An; Yun Kyu Oh; Chun Soo Lim; Dong Ki Kim; Yon Su Kim; Kyungho Choi; Jung Pyo Lee
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-22       Impact factor: 8.237

3.  Tubular secretion in chronic kidney disease staging: a new proposal.

Authors:  Carlos G Musso; Cristina Gavrilovici; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2017-08-03       Impact factor: 2.370

4.  The CKD Classification System in the Precision Medicine Era.

Authors:  Yoshio N Hall; Jonathan Himmelfarb
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-30       Impact factor: 8.237

5.  Residual kidney function in twice-weekly hemodialysis: irreplaceable contribution to dialysis adequacy.

Authors:  Yu-Ji Lee; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Ann Transl Med       Date:  2018-08

6.  Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.

Authors:  Matthew B Rivara; Leila R Zelnick; Andrew N Hoofnagle; Rick Newitt; Russell P Tracy; Mario Kratz; David S Weigle; Bryan R Kestenbaum
Journal:  Clin Chem       Date:  2017-02-10       Impact factor: 8.327

Review 7.  Comprehensive Assessment of Kidney Health in Acute Kidney Injury: Can It Be Achieved?

Authors:  Etienne Macedo; Camila Lima
Journal:  Nephron       Date:  2019-09-18       Impact factor: 2.847

8.  Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.

Authors:  Kevin T Bush; Prabhleen Singh; Sanjay K Nigam
Journal:  JCI Insight       Date:  2020-04-09

Review 9.  Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.

Authors:  Ke Wang; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-28       Impact factor: 8.237

10.  Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.

Authors:  Sheldon C Leong; Justin N Sao; Abigail Taussig; Natalie S Plummer; Timothy W Meyer; Tammy L Sirich
Journal:  J Am Soc Nephrol       Date:  2018-05-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.